To make an appointment, please call 1-800-KARMANOS (1-800-527-6266) or request an appointment online
As a leader in cancer research, Karmanos is able to offer patients access to innovative treatments and clinical trials that are often times not available anywhere else.
To offer hope and longer life to patients with all types of cancer, Karmanos offers the latest types of therapy through our clinical trials program. Through clinical trials, we are creating new knowledge about how therapies fight cancer and provide national leadership in testing these new therapies.
We understand that cancer is a complex disease that demands complex care. We provide each patient with a dynamic, carefully constructed treatment plan focused on their specific cancer and their unique needs.
We listen to you to design a plan that provides you with respect, compassionate care and is responsive to your emotional and practical concerns.
Notification: We are pleased to share that our information technology platforms are restored, and our clinics are fully functional across Michigan. Click here for more information.
97.1 The Ticket | 1270 AM The Bet | 99.5 WYCD | 104.3 WOMC | ALT 98.7
Though cervical cancer can be detected early by routine screenings and is preventable with the HPV vaccine, physicians diagnose some later stages of the disease. John Wallbillich, M.D., gynecologic oncologist and member of the Gynecologic Oncology Multidisciplinary Team at Karmanos, said this could be due to access. He explains cervical cancer screenings, the HPV vaccine, how immunotherapy works, and how Karmanos is at the forefront of research and treatment. On Sunday Edition, he explains how Karmanos was involved in the clinical trials of the recently FDA-approved treatment therapy of KEYTRUDA (pembrolizumab) in combination with chemoradiotherapy for patients with FIGO 2014 stage III-IVA cervical cancer.
Your browser does not support the audio element.
Download Podcast